Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transdermal therapeutic system for the transdermal administration of rivastigmine

Transdermal therapeutic system for the transdermal administration of rivastigmine

US Patent 11389421 · Granted Jul 19, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Transdermal delivery system including an interface mediator2025
Transdermal therapeutic system for the transdermal administration of guanfacine 2025
Transdermal therapeutic system for the transdermal administration of guanfacine 2024
Method for adjusting the release of active agent in a transdermal delivery syste2024
Transdermal therapeutic system for the transdermal administration of guanfacine 2024
Transdermal delivery system including an interface mediator2023
Transdermal delivery system containing rotigotine2023
Transdermal therapeutic system for the transdermal administration of guanfacine 2023
Method for adjusting the release of active agent in a transdermal delivery syste2022
Multi-day patch for the transdermal administration of rotigotine2022
Control of adhesive domains2021
Transdermal therapeutic system comprising an electronic component2021